https://www.sciencedirect.com/science/article/pii/S0960076020302764?via%3Dihub
Conclusion
"Our
pilot study demonstrated that administration of a high dose of
Calcifediol or 25-hydroxyvitamin D, a main metabolite of vitamin D
endocrine system, significantly reduced the need for ICU treatment of
patients requiring hospitalization due to proven COVID-19."
Entrenas Castillo, M., Entrenas Costa, L. M., Vaquero Barrios, J. M., Alcalá Díaz, J. F., López Miranda, J., Bouillon, R. & Quesada Gomez, J. M. (2020). “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”. The Journal of Steroid Biochemistry and Molecular Biology, 203, s. 105751. doi:https://doi.org/10.1016/j.jsbmb.2020.105751
